0000950170-23-070146.txt : 20231213
0000950170-23-070146.hdr.sgml : 20231213
20231213200250
ACCESSION NUMBER: 0000950170-23-070146
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20231213
DATE AS OF CHANGE: 20231213
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Xenon Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001582313
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 980661854
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-36687
FILM NUMBER: 231485302
BUSINESS ADDRESS:
STREET 1: 200 - 3650 GILMORE WAY
CITY: BURNABY
STATE: A1
ZIP: V5G 48W
BUSINESS PHONE: (604) 484-3300
MAIL ADDRESS:
STREET 1: 200 - 3650 GILMORE WAY
CITY: BURNABY
STATE: A1
ZIP: V5G 48W
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: PATOU GARY
CENTRAL INDEX KEY: 0001283535
FILING VALUES:
FORM TYPE: 144
144
1
primary_doc.xml
144
0001283535
XXXXXXXX
LIVE
0001582313
Xenon Pharmaceuticals Inc.
001-36687
200-3650 Gilmore Way
Burnaby
A1
V5G 4W8
(604)-484-3300
GARY PATOU
Director
Common Shares
Morgan Stanley Wealth Management Canada Inc.
Suite 1500, 600 - 3 Avenue SW
Calgary
Z4
T2P 0G5
11380
454062
65429711
12/13/2023
NASDAQ
Common Shares
12/13/2023
Exercise of options
Issuer
N
11380
12/13/2023
Net Exercise
Y
Pursuant to the terms of a lock-up agreement executed by the undersigned in favor of the underwriters of the Company's November 2023 follow-on public offering, the undersigned is permitted to transfer up to 22,000 common shares during the lock-up period.
12/13/2023
Gary Patou